Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Hemostemix Inc (HMTXF)

Hemostemix Inc (HMTXF)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0640 -0.0054 (-7.78%) 04/22/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0640 unch (unch) 10:37 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.0610
Day High
0.0640
Open 0.0610
Previous Close 0.0694 0.0694
Volume 2,300 2,300
Avg Vol 18,345 18,345
Stochastic %K 40.60% 40.60%
Weighted Alpha -64.06 -64.06
5-Day Change -0.0025 (-3.76%) -0.0025 (-3.76%)
52-Week Range 0.0240 - 0.2850 0.0240 - 0.2850
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0540 +18.52%
on 03/31/25
Period Open: 0.0818
0.0875 -26.86%
on 03/25/25
-0.0178 (-21.76%)
since 03/21/25
3-Month
0.0540 +18.52%
on 03/31/25
Period Open: 0.2048
0.2850 -77.54%
on 01/24/25
-0.1408 (-68.75%)
since 01/22/25
52-Week
0.0240 +166.67%
on 07/22/24
Period Open: 0.0371
0.2850 -77.54%
on 01/24/25
+0.0269 (+72.51%)
since 04/11/24

Most Recent Stories

More News
Hemostemix Engages PatentVest to Strengthen its Global Patent Portfolio

Calgary, Alberta--(Newsfile Corp. - April 23, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) a leader in the development of autologous stem cell therapy for the treatment of cardiovascular...

HMTXF : 0.0640 (-7.78%)
HEM.VN : 0.095 (+5.56%)
Hemostemix's Pitch to Wall Street: ACP-01 Vascular Dementia Trial will Generate $5,365,000, Capture Data, as a Phase 1 Clinical Trial

Calgary, Alberta--(Newsfile Corp. - March 17, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or "HEM"), an autologous angiogenic stem cell company that has safely treated...

HMTXF : 0.0640 (-7.78%)
HEM.VN : 0.095 (+5.56%)
Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01

A growing body of clinical evidence supports the use of Firefly's FDA-Cleared BNA(TM) platform to study ACP-01 as a treatment for vascular dementiaCalgary, Alberta--(Newsfile Corp. - March 6, 2025) - Hemostemix...

AIFF : 3.10 (+0.65%)
HMTXF : 0.0640 (-7.78%)
HEM.VN : 0.095 (+5.56%)
Hemostemix Sells Its 23rd ACP-01 Therapy Convertible Debenture

Calgary, Alberta--(Newsfile Corp. - March 5, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or "HEM"), an autologous angiogenic stem cell therapy company that has safely...

HMTXF : 0.0640 (-7.78%)
HEM.VN : 0.095 (+5.56%)
RETRANSMISSION: Hemostemix Licenses CytoImmune's BioReactor Technologies

Calgary, Alberta--(Newsfile Corp. - February 20, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is delighted to announce a strategic breakthrough that secures...

HMTXF : 0.0640 (-7.78%)
HEM.VN : 0.095 (+5.56%)
Hemostemix Licenses CytoImmune's BioReactor Technologies

Calgary, Alberta--(Newsfile Corp. - February 19, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is delighted to announce a strategic breakthrough that secures...

HMTXF : 0.0640 (-7.78%)
HEM.VN : 0.095 (+5.56%)
Hemostemix Provides Corporate Update

Calgary, Alberta--(Newsfile Corp. - February 13, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") announces that, at the request of the Canadian Investment...

HMTXF : 0.0640 (-7.78%)
HEM.VN : 0.095 (+5.56%)
Hemostemix PR Inc. Congratulates Luis Munoz Marin International Airport on Achieving CEIV Pharma Certification

San Juan, Puerto Rico--(Newsfile Corp. - February 11, 2025) - Hemostemix PR Inc. proudly congratulates Luis Muñoz Marín International Airport (SJU) on achieving the prestigious CEIV Pharma Certification...

HMTXF : 0.0640 (-7.78%)
HEM.VN : 0.095 (+5.56%)
Hemostemix Contracts ProConsul to Ramp up Engagement with New Investors

Calgary, Alberta--(Newsfile Corp. - February 10, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is excited to announce that it has engaged ProConsul Capital...

HMTXF : 0.0640 (-7.78%)
HEM.VN : 0.095 (+5.56%)
CytoImmune Subscribes for 1,634,466 Hemostemix Common Shares

Calgary, Alberta--(Newsfile Corp. - February 4, 2025) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is delighted to announce that CytoImmune is subscribing USD...

HMTXF : 0.0640 (-7.78%)
HEM.VN : 0.095 (+5.56%)

Key Turning Points

3rd Resistance Point 0.0680
2nd Resistance Point 0.0660
1st Resistance Point 0.0650
Last Price 0.0640
1st Support Level 0.0620
2nd Support Level 0.0600
3rd Support Level 0.0590

See More

52-Week High 0.2850
Fibonacci 61.8% 0.1853
Fibonacci 50% 0.1545
Fibonacci 38.2% 0.1237
Last Price 0.0640
52-Week Low 0.0240

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective